Pantoflux (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Erosive esophagitis: heals existing ulcerations in the esophageal lining.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare neuroendocrine tumor.
• Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk.
• Maintenance therapy after healed erosive esophagitis: helps prevent relapse of symptoms.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump in its active state, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduction of gastric acidity.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: excess gas formation.
• Constipation: infrequent.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): requires immediate medical attention.
• Clostridioides difficile infection: may present with watery diarrhea.
• Low magnesium levels (hypomagnesemia): can cause muscle cramps or arrhythmia.
• Bone fracture risk with long‑term use: especially in elderly patients.
• Liver enzyme elevation: indicates possible hepatic involvement.
• Acute interstitial nephritis: rare kidney inflammation.

Before starting Pantoflux, consider the following safety points:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review liver disease status: use with caution in moderate to severe hepatic impairment.
• Evaluate need for long‑term therapy: prolonged use may increase fracture risk.
• Monitor for magnesium levels: especially if therapy exceeds three months.
• Consider drug‑interaction potential: check concomitant medications for CYP‑related effects.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid)

• Ketoconazole or itraconazole: reduced antifungal absorption.
• Atazanavir: decreased antiviral exposure.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR.
• Digoxin: slight rise in serum levels.
• Methotrexate: reduced renal clearance at high doses.
• Mycophenolate mofetil: increased exposure.
• Iron supplements: lower iron absorption when taken simultaneously.